AI reads your skin: new tool aims to help doctors spot rashes and moles

NCT ID NCT07033169

Recruiting now Diagnosis Sponsor: Wake Forest University Health Sciences Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a software tool called Belle.ai that uses artificial intelligence to help doctors diagnose common skin diseases. About 400 patients at dermatology clinics will have three photos taken of their skin condition. The AI will analyze the photos and suggest possible diagnoses, which will then be compared to the diagnoses made by a panel of board-certified dermatologists. The goal is to see how well the AI matches expert opinion.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Belle.ai software (AI image analysis tool)
What this could lead to: If successful, this AI tool could help doctors diagnose skin conditions more quickly and accurately, potentially reducing misdiagnosis.
What could go wrong: This is an early-stage study focused on comparing AI diagnoses to doctor diagnoses, not on patient outcomes. The AI may not work well for all skin types or conditions, and it is not a replacement for a doctor's judgment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DERMATOLOGIC DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

skin disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DERMATOLOGIC DISEASE

Contacts and locations

Locations

Wake Forest University Health Sciences Department of Dermatology
RECRUITING

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.